GBA1 and Parkinson disease: GCase pathology in the context of heterozygous GBA mutations in PD have been addressed in recent postmortem (Gegg et al., 2012) and patient fibroblast (McNeill et al., 2014) studies, and recently in a PD patient human neuronal model (Schöndorf et al., 2014).